Is CNMD undervalued or overvalued?
As of 2025-03-26, the Intrinsic Value of Conmed Corp (CNMD) is 84.19 USD. This CNMD valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 60.80 USD, the upside of Conmed Corp is 38.50%. This means that CNMD is undervalued by 38.50%.
The range of the Intrinsic Value is 57.77 - 138.29 USD
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 57.77 - 138.29 | 84.19 | 38.5% |
| DCF (Growth 10y) | 83.22 - 180.30 | 115.32 | 89.7% |
| DCF (EBITDA 5y) | 101.54 - 157.62 | 130.30 | 114.3% |
| DCF (EBITDA 10y) | 124.28 - 194.53 | 158.51 | 160.7% |
| Fair Value | 106.28 - 106.28 | 106.28 | 74.80% |
| P/E | 159.88 - 201.00 | 184.67 | 203.7% |
| EV/EBITDA | 95.15 - 185.57 | 131.16 | 115.7% |
| EPV | 61.90 - 90.00 | 75.95 | 24.9% |
| DDM - Stable | 28.15 - 67.06 | 47.61 | -21.7% |
| DDM - Multi | 46.94 - 87.36 | 61.11 | 0.5% |
| Market Cap (mil) | 1,879.33 |
| Beta | 0.07 |
| Outstanding shares (mil) | 30.91 |
| Enterprise Value (mil) | 1,879.33 |
| Market risk premium | 4.60% |
| Cost of Equity | 10.20% |
| Cost of Debt | 4.47% |
| WACC | 8.02% |